Codexis (CDXS) Capital Expenditures (2010 - 2026)
Codexis (CDXS) recorded quarterly Capital Expenditures of $176000.0 in Q1 2026, up 104.49% quarter-over-quarter from -$3.9 million in Q4 2025, and down 91.51% on a YoY basis from $2.1 million in Q1 2025.
Codexis (CDXS) Capital Expenditures (2010 - 2026) Analysis & Trends
Codexis' Capital Expenditures history runs 17 years deep, the most recent figure standing at $176000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures fell 91.51% year-over-year to $176000.0; the TTM figure through Mar 2026 stood at -$1.9 million (down 131.06% YoY), while the FY2025 annual figure was $31000.0, down 99.28% from the prior year.
- Capital Expenditures was $176000.0 for Q1 2026 at Codexis, up from -$3.9 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $8.2 million in Q4 2022 to a low of -$6.9 million in Q3 2022.
- Historically, Capital Expenditures has averaged $816882.4 across 5 years, with a median of $819000.0 in 2023.
- The sharpest annual moves came in 2022 and 2025: Capital Expenditures jumped 1469.87% in 2022, then slumped 610.08% in 2025.
- A 5-year view of Capital Expenditures shows it stood at $8.2 million in 2022, then sank by 145.6% to -$3.7 million in 2023, then surged by 147.56% to $1.8 million in 2024, then plunged by 320.97% to -$3.9 million in 2025, then jumped by 104.49% to $176000.0 in 2026.
- The last three Capital Expenditures figures came in at $176000.0 (Q1 2026), -$3.9 million (Q4 2025), and $3.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -63,220.27 |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn | 176,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 176,000.00 |
| Mar 31, 2026 | 176,000.00 |
| Dec 31, 2025 | -3.92 Mn |
| Dec 31, 2025 | -3.92 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Sep 30, 2025 | 3.90 Mn |
| Jun 30, 2025 | -2.03 Mn |
| Jun 30, 2025 | -2.03 Mn |
| Mar 31, 2025 | 2.07 Mn |
| Mar 31, 2025 | 2.07 Mn |
| Dec 31, 2024 | 1.77 Mn |
| Dec 31, 2024 | 1.77 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 397,000.00 |
| Jun 30, 2024 | 397,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Mar 31, 2024 | 371,000.00 |
| Dec 31, 2023 | -3.73 Mn |
| Dec 31, 2023 | -3.73 Mn |